Literature DB >> 8578814

Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of Plasmodium falciparum in the mouse.

M Tsuji1, C Ishihara, S Arai, R Hiratai, I Azuma.   

Abstract

Our previous study has demonstrated that repeated transfusions of bovine red blood cells (RBCs) into SCID mice resulted in a complete substitution of their circulating RBCs. Identical experiments with human (Hu) RBCs, however, gave rise to a poor RBC-substitution because of the rapid elimination of Hu-RBCs from the circulation of SCID mice. Search for substances to decelerate the Hu-RBC clearance picked up some effective polysaccharides, such as sulfated chitin and mannan, but they were not effective enough to achieve a high level of Hu-RBC-substitution. In the present study, we found that Hu-serum significantly extended the lifetime of Hu-RBC in SCID mice and that repeated transfusions of the mice with Hu-RBCs, in combination with Hu-serum administration, resulted in an almost complete substitution of their circulating RBCs. An Hu-RBC-substituted SCID mouse inoculated with Plasmodium falciparum had a parasitemia persisting for two weeks, indicating a possible growth of this parasite in the mouse. Thus, this report gave the first demonstration of a complete substitution of the circulating RBCs in SCID mice with Hu-RBCs and of a successful P. falciparum infection in the mice.

Entities:  

Mesh:

Year:  1995        PMID: 8578814     DOI: 10.1016/0264-410x(95)00081-b

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Experimental infection of immunomodulated NOD/LtSz-SCID mice as a new model for Plasmodium falciparum erythrocytic stages.

Authors:  Alicia Moreno Sabater; Marta Moreno; Francisco Javier Moreno; Cesar Eguiluz; Nico van Rooijen; Agustin Benito
Journal:  Parasitol Res       Date:  2004-12-10       Impact factor: 2.289

2.  Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Authors:  Sebastian A Mikolajczak; John B Sacci; Patricia De La Vega; Nelly Camargo; Kelly VanBuskirk; Urszula Krzych; Jun Cao; Marcelo Jacobs-Lorena; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

3.  Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice.

Authors:  A Saito-Ito; M Tsuji; Q Wei; S He; T Matsui; M Kohsaki; S Arai; T Kamiyama; K Hioki; C Ishihara
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic.

Authors:  Q Wei; M Tsuji; A Zamoto; M Kohsaki; T Matsui; T Shiota; S R Telford; C Ishihara
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.

Authors:  Rosemary Rochford; Colin Ohrt; Paul C Baresel; Brice Campo; Aruna Sampath; Alan J Magill; Babu L Tekwani; Larry A Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

6.  Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells.

Authors:  Qingfeng Chen; Anburaj Amaladoss; Weijian Ye; Min Liu; Sara Dummler; Fang Kong; Lan Hiong Wong; Hooi Linn Loo; Eva Loh; Shu Qi Tan; Thiam Chye Tan; Kenneth T E Chang; Ming Dao; Subra Suresh; Peter R Preiser; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 7.  Development of humanized mouse models to study human malaria parasite infection.

Authors:  Ashley M Vaughan; Stefan H I Kappe; Alexander Ploss; Sebastian A Mikolajczak
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

8.  Analysis of innate defences against Plasmodium falciparum in immunodeficient mice.

Authors:  Ludovic Arnold; Rajeev Kumar Tyagi; Pedro Mejia; Nico Van Rooijen; Jean-Louis Pérignon; Pierre Druilhe
Journal:  Malar J       Date:  2010-07-09       Impact factor: 2.979

9.  Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum.

Authors:  E Badell; C Oeuvray; A Moreno; S Soe; N van Rooijen; A Bouzidi; P Druilhe
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes.

Authors:  Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Teresa Mulet; Joaquín Rullas; Esperanza Herreros; Santiago Ferrer; Elena Jiménez; Alfonso Mendoza; Javier Regadera; Philip J Rosenthal; Ian Bathurst; David L Pompliano; Federico Gómez de las Heras; Domingo Gargallo-Viola
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.